UKMEC 2025 · CoSRH educational reference

UKMEC 2025 reference

An interactive way to view the published UKMEC 2025 criteria for the six main contraceptive methods. Select scenario factors on the left to reveal the relevant sections of CoSRH guidance. Read the full CoSRH document before any clinical decision.

Educational reference — not a medical device. This page surfaces excerpts from CoSRH UKMEC 2025 based on the filters you select. It makes no clinical assessment, gives no patient-specific recommendation, and is not a substitute for the full CoSRH guidance. All clinical judgement, prescribing decisions, and patient assessment remain entirely with the qualified healthcare professional. Categories shown are CoSRH’s published wording; interpretation is the reader’s. Intended for UK healthcare professionals as a quick way to navigate the published criteria.

Scenario filters

Select factors to reveal the relevant sections of UKMEC 2025. All optional.

Demographics & vitals

Age (years)

Height (cm)

Weight (kg)

Systolic BP (mmHg)

Diastolic BP (mmHg)

BP measurement source

UKMEC 2025 uses NICE classification. Home/ABPM thresholds are 5 mmHg lower than clinic readings.

Smoking status

Cardiovascular & thrombotic

Personal history of VTE DVT, PE — current or past Known thrombogenic mutation Factor V Leiden, prothrombin, protein C/S/antithrombin deficiency Ischaemic heart disease (current or past) Stroke or TIA (current or past) Multiple cardiovascular risk factors e.g. older age + smoking + diabetes + hypertension Major surgery with prolonged immobilisation

Neurological & rheumatological

Migraine

Multiple sclerosis

Added to UKMEC 2025.

SLE with positive/unknown antiphospholipid antibodies

Endocrine & metabolic

Diabetes

Oncological & hepatic

Breast cancer

UKMEC 2025 clarifies “current treatment” includes the years on tamoxifen or aromatase inhibitors.

Liver disease

Postpartum & pregnancy

Postpartum status

Renal, haematological & HIV

Chronic kidney disease

Added to UKMEC 2025.

HIV status

UKMEC 2025 categorises by clinical status, not CD4 count.

Sickle cell trait Added to UKMEC 2025

Drug interactions & IUC-specific

On enzyme-inducing drugs Carbamazepine, phenytoin, rifampicin, St John’s wort, some antiretrovirals Current PID or purulent cervicitis Distorted uterine cavity Fibroids distorting cavity, congenital anomaly Unexplained vaginal bleeding (before evaluation) Wilson’s disease

Relevant UKMEC criteria

Published UKMEC 2025 rows matching your selected filters. Categories shown are CoSRH’s published wording.

UKMEC key 1 No restriction 2 Advantages outweigh risks 3 Risks usually outweigh 4 Unacceptable risk

∅

Select filters on the left, then press Show UKMEC criteria to view the matching rows from UKMEC 2025.

About A free educational reference implementing the CoSRH UKMEC 2025 framework. Built by a UK GP for UK clinicians. Surfaces published guidance — does not make clinical assessments. Feedback welcome.

Contact & feedback [email protected]
Bug reports, suggested features, and clinical corrections appreciated.

Source UKMEC content © CoSRH 2025. Reproduced for non-commercial educational reference under CoSRH’s reproduction permission. See the full CoSRH UKMEC 2025 guidance.

Privacy No cookies. No analytics. No tracking. No data leaves your browser — all filtering runs locally on your device. Nothing you enter is stored or transmitted.

Version 2.0 · Last reviewed 22 May 2026 · Next review due November 2026 · © 2026 Dr BN · Educational reference, not a medical device